Logo image of CPR.MI

DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis

BIT:CPR - Borsa Italiana Milan - NL0015435975 - Common Stock - Currency: EUR

5.248  -0.13 (-2.45%)

Fundamental Rating

4

CPR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 24 industry peers in the Beverages industry. CPR has an average financial health and profitability rating. CPR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year CPR was profitable.
In the past year CPR had a positive cash flow from operations.
CPR had positive earnings in each of the past 5 years.
Each year in the past 5 years CPR had a positive operating cash flow.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

1.2 Ratios

With a decent Return On Assets value of 4.00%, CPR is doing good in the industry, outperforming 61.90% of the companies in the same industry.
CPR has a Return On Equity (8.77%) which is comparable to the rest of the industry.
CPR has a Return On Invested Capital of 6.05%. This is in the lower half of the industry: CPR underperforms 76.19% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CPR is in line with the industry average of 8.61%.
Industry RankSector Rank
ROA 4%
ROE 8.77%
ROIC 6.05%
ROA(3y)5.36%
ROA(5y)5.32%
ROE(3y)11.92%
ROE(5y)11.62%
ROIC(3y)7.65%
ROIC(5y)7.25%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

CPR's Profit Margin of 11.17% is fine compared to the rest of the industry. CPR outperforms 61.90% of its industry peers.
CPR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 20.66%, CPR is in line with its industry, outperforming 52.38% of the companies in the same industry.
In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
Looking at the Gross Margin, with a value of 57.81%, CPR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
Industry RankSector Rank
OM 20.66%
PM (TTM) 11.17%
GM 57.81%
OM growth 3Y7.15%
OM growth 5Y-1.01%
PM growth 3Y2.21%
PM growth 5Y-8.14%
GM growth 3Y0.2%
GM growth 5Y-0.61%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
CPR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CPR has been increased compared to 5 years ago.
CPR has a worse debt/assets ratio than last year.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.38 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.38, CPR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Debt/Equity ratio of 0.66 indicates that CPR is somewhat dependend on debt financing.
The Debt to Equity ratio of CPR (0.66) is better than 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Altman-Z 2.38
ROIC/WACC0.92
WACC6.61%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B

2.3 Liquidity

CPR has a Current Ratio of 2.61. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.61, CPR belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
A Quick Ratio of 1.06 indicates that CPR should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.06, CPR belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.61
Quick Ratio 1.06
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CPR have decreased strongly by -39.21% in the last year.
The Earnings Per Share has been growing slightly by 2.93% on average over the past years.
Looking at the last year, CPR shows a small growth in Revenue. The Revenue has grown by 2.96% in the last year.
The Revenue has been growing by 11.26% on average over the past years. This is quite good.
EPS 1Y (TTM)-39.21%
EPS 3Y21.31%
EPS 5Y2.93%
EPS Q2Q%-53.38%
Revenue 1Y (TTM)2.96%
Revenue growth 3Y18.1%
Revenue growth 5Y11.26%
Sales Q2Q%4.5%

3.2 Future

Based on estimates for the next years, CPR will show a small growth in Earnings Per Share. The EPS will grow by 6.95% on average per year.
Based on estimates for the next years, CPR will show a small growth in Revenue. The Revenue will grow by 5.48% on average per year.
EPS Next Y-13.43%
EPS Next 2Y-3.51%
EPS Next 3Y2.11%
EPS Next 5Y6.95%
Revenue Next Year3.21%
Revenue Next 2Y4.64%
Revenue Next 3Y5.15%
Revenue Next 5Y5.48%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.2 0.4 0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.62, CPR can be considered very expensive at the moment.
CPR's Price/Earnings ratio is a bit more expensive when compared to the industry. CPR is more expensive than 76.19% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.47, CPR is valued at the same level.
The Price/Forward Earnings ratio is 16.44, which indicates a correct valuation of CPR.
66.67% of the companies in the same industry are cheaper than CPR, based on the Price/Forward Earnings ratio.
CPR is valuated cheaply when we compare the Price/Forward Earnings ratio to 92.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.62
Fwd PE 16.44
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CPR's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CPR is more expensive than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)9.43
EPS Next 2Y-3.51%
EPS Next 3Y2.11%

More info and screens

2

5. Dividend

5.1 Amount

CPR has a Yearly Dividend Yield of 1.15%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.86, CPR's dividend is way lower than its industry peers. On top of this 90.48% of the companies listed in the same industry pay a better dividend than CPR!
Compared to an average S&P500 Dividend Yield of 2.28, CPR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.15%

5.2 History

The dividend of CPR decreases each year by -4.99%.
Dividend Growth(5Y)-4.99%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CPR pays out 23.43% of its income as dividend. This is a sustainable payout ratio.
DP23.43%
EPS Next 2Y-3.51%
EPS Next 3Y2.11%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

More info and screens

DAVIDE CAMPARI-MILANO NV

BIT:CPR (2/5/2025, 5:35:15 PM)

5.248

-0.13 (-2.45%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)10-29 2024-10-29
Earnings (Next)N/A N/A
Inst Owners24.07%
Inst Owner ChangeN/A
Ins Owners51.32%
Ins Owner ChangeN/A
Market Cap6.46B
Analysts72.59
Price Target8.04 (53.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.15%
Yearly Dividend0.04
Dividend Growth(5Y)-4.99%
DP23.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.11%
PT rev (3m)-18.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.91%
EPS NY rev (3m)-4.91%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.58%
Revenue NY rev (3m)-2.58%
Valuation
Industry RankSector Rank
PE 27.62
Fwd PE 16.44
P/S 2.17
P/FCF N/A
P/OCF 15.59
P/B 1.7
P/tB N/A
EV/EBITDA 12
EPS(TTM)0.19
EY3.62%
EPS(NY)0.32
Fwd EY6.08%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.34
OCFY6.42%
SpS2.42
BVpS3.09
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)9.43
Profitability
Industry RankSector Rank
ROA 4%
ROE 8.77%
ROCE 8.58%
ROIC 6.05%
ROICexc 6.56%
ROICexgc 15.85%
OM 20.66%
PM (TTM) 11.17%
GM 57.81%
FCFM N/A
ROA(3y)5.36%
ROA(5y)5.32%
ROE(3y)11.92%
ROE(5y)11.62%
ROIC(3y)7.65%
ROIC(5y)7.25%
ROICexc(3y)8.83%
ROICexc(5y)8.52%
ROICexgc(3y)27.99%
ROICexgc(5y)32.96%
ROCE(3y)10.84%
ROCE(5y)10.28%
ROICexcg growth 3Y1.19%
ROICexcg growth 5Y-3.69%
ROICexc growth 3Y11.02%
ROICexc growth 5Y1.99%
OM growth 3Y7.15%
OM growth 5Y-1.01%
PM growth 3Y2.21%
PM growth 5Y-8.14%
GM growth 3Y0.2%
GM growth 5Y-0.61%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Debt/EBITDA 3.44
Cap/Depr 380.97%
Cap/Sales 15.03%
Interest Coverage 7.15
Cash Conversion 56.46%
Profit Quality N/A
Current Ratio 2.61
Quick Ratio 1.06
Altman-Z 2.38
F-Score4
WACC6.61%
ROIC/WACC0.92
Cap/Depr(3y)287.22%
Cap/Depr(5y)219.67%
Cap/Sales(3y)10.23%
Cap/Sales(5y)8.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.21%
EPS 3Y21.31%
EPS 5Y2.93%
EPS Q2Q%-53.38%
EPS Next Y-13.43%
EPS Next 2Y-3.51%
EPS Next 3Y2.11%
EPS Next 5Y6.95%
Revenue 1Y (TTM)2.96%
Revenue growth 3Y18.1%
Revenue growth 5Y11.26%
Sales Q2Q%4.5%
Revenue Next Year3.21%
Revenue Next 2Y4.64%
Revenue Next 3Y5.15%
Revenue Next 5Y5.48%
EBIT growth 1Y1.15%
EBIT growth 3Y26.54%
EBIT growth 5Y10.13%
EBIT Next Year20.73%
EBIT Next 3Y13.92%
EBIT Next 5Y10.83%
FCF growth 1Y-112.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.66%
OCF growth 3Y-16.84%
OCF growth 5Y-13.83%